fluoxetine has been researched along with triiodothyronine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (35.71) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 10 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Evans, DL; Golden, RN; Mundle, LB; Nagy, BR; Petitto, JM | 1 |
| Joffe, RT | 1 |
| Geracioti, TD; Gold, PW; Kling, MA; Loosen, PT | 1 |
| Gupta, S; Masand, P; Tanquary, JF | 1 |
| Nierenberg, AA | 1 |
| Extein, IL | 1 |
| Bross, R; Hoffer, LJ | 1 |
| Abraham, ME; Fava, M; Labbate, LA; Rosenbaum, JF | 1 |
| Baumgartner, A; Campos-Barros, A; Dubeyko, M; Eravci, M; Meinhold, H | 1 |
| Ekhatore, N; Loosen, PT; Shelton, RC; Winn, S | 1 |
| Agid, O; Lerer, B; Shalev, AY | 1 |
| Alpert, JE; Fava, M; Howarth, S; Iosifescu, DV; Nierenberg, AA; Worthington, JJ | 1 |
| Agid, O; Lerer, B | 1 |
| Gur, E; Lerer, B; Lifschytz, T; Newman, ME | 1 |
| Lerer, B; Lifschytz, T; Newman, ME; Shalom, G | 1 |
| Jiang, FX; Kong, LD; Kung, HF; Li, YC; Pan, Y; Xia, X | 1 |
| Bridel, MA; Christofides, J; Cowlard, R; Darlington, LG; Forrest, CM; Mackay, GM; Mitchell, S; Stone, TW | 1 |
| Bahls, SC; Boeving, A; de Carvalho, GA; Graf, H | 1 |
| Ben-Hur, T; Einstein, O; Eitan, R; Landshut, G; Lerer, B; Lifschytz, T | 1 |
| Goltser-Dubner, T; Landshut, G; Lerer, B; Lifschytz, T | 1 |
| Araujo, IG; Côrtes, WS; Marassi, MP; Mecawi, AS; Olivares, EL; Pestana, FM; Reis, LC; Rocha, FF; Rodrigues, NC; Silva-Almeida, C; Sonoda-Côrtes, R | 1 |
1 review(s) available for fluoxetine and triiodothyronine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 trial(s) available for fluoxetine and triiodothyronine
| Article | Year |
|---|---|
Fluoxetine increases resting energy expenditure and basal body temperature in humans.
Topics: Adult; Body Temperature; Chemotherapy, Adjuvant; Diet, Reducing; Double-Blind Method; Energy Metabolism; Female; Fluoxetine; Humans; Norepinephrine; Obesity; Rest; Serotonin Antagonists; Thyroxine; Triiodothyronine; Weight Loss | 1995 |
Hypothyroidism and hyperthyroidism in major depression revisited.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle Aged; Prevalence; Sex Factors; Thyroid Function Tests; Thyroid Hormones; Thyrotropin; Thyroxine; Treatment Outcome; Triiodothyronine | 1995 |
Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder.
Topics: Adult; Ambulatory Care; Depression; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stress Disorders, Post-Traumatic; Treatment Outcome; Triiodothyronine | 2001 |
T3 blood levels and treatment outcome in depression.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Radioimmunoassay; Selective Serotonin Reuptake Inhibitors; Triiodothyronine | 2001 |
Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation.
Topics: Adult; Aged; Algorithms; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluoxetine; Humans; Male; Middle Aged; Outpatients; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Triiodothyronine | 2003 |
Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling.
Topics: Adult; Antidepressive Agents; Biomarkers; Counseling; Depression; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Inflammation; Kynurenine; Male; Middle Aged; Psychotherapy; Serotonin; Triiodothyronine | 2009 |
Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function.
Topics: Adult; Aged; Autoantibodies; Depressive Disorder, Major; Fluoxetine; Humans; Hypothyroidism; Iodide Peroxidase; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 2009 |
20 other study(ies) available for fluoxetine and triiodothyronine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Improvement of arthritis with fluoxetine.
Topics: Arthritis; Female; Fluoxetine; Humans; Middle Aged; Migraine Disorders; Pain; Selective Serotonin Reuptake Inhibitors; Triiodothyronine | 1992 |
Triiodothyronine potentiation of fluoxetine in depressed patients.
Topics: Adult; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Triiodothyronine | 1992 |
Cortisol, thyroid hormone, and mood in atypical depression: a longitudinal case study.
Topics: Adult; Affect; Depressive Disorder; Disorders of Excessive Somnolence; Female; Fluoxetine; Humans; Hydrocortisone; Hyperphagia; Hypothalamo-Hypophyseal System; Longitudinal Studies; Pituitary-Adrenal System; Thyroid Gland; Thyroid Hormones; Triiodothyronine | 1992 |
Thyroid hormone supplementation of fluoxetine in the treatment of major depression.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Psychotherapy; Triiodothyronine | 1991 |
Treatment choice after one antidepressant fails: a survey of northeastern psychiatrists.
Topics: Antidepressive Agents; Attitude of Health Personnel; Bupropion; Decision Making; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium; Nortriptyline; Propiophenones; Psychiatry; Triiodothyronine | 1991 |
Recent fluoxetine treatment and complications of tricyclic therapy.
Topics: Depressive Disorder; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Nortriptyline; Triiodothyronine | 1991 |
Subchronic administration of fluoxetine to rats affects triiodothyronine production and deiodination in regions of the cortex and in the limbic forebrain.
Topics: Animals; Cerebral Cortex; Fluoxetine; Iodide Peroxidase; Limbic System; Male; Prosencephalon; Rats; Rats, Sprague-Dawley; Time Factors; Triiodothyronine | 1994 |
The effects of antidepressants on the thyroid axis in depression.
Topics: Ambulatory Care; Antidepressive Agents; Depressive Disorder; Desipramine; Female; Fluoxetine; Humans; Male; Thyroid Gland; Thyroid Hormones; Thyroxine; Triiodothyronine | 1993 |
Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autoreceptors; Brain; Brain Chemistry; Depressive Disorder; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Hypothalamus; Male; Microdialysis; Neurochemistry; Prefrontal Cortex; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin; Triiodothyronine | 2004 |
Sex-dependent effects of fluoxetine and triiodothyronine in the forced swim test in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Depression; Female; Fluoxetine; Male; Motor Activity; Rats; Rats, Wistar; Sex Characteristics; Swimming; Triiodothyronine | 2006 |
Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats.
Topics: Adrenocorticotropic Hormone; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Chronic Disease; Corticotropin-Releasing Hormone; Depression; Epimedium; Flavonoids; Fluoxetine; Food Preferences; Male; Neurotransmitter Agents; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Sucrose; Thyroxine; Triiodothyronine | 2007 |
The thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: possible role in antidepressant-augmenting properties.
Topics: Animals; Antidepressive Agents; Depression; Doublecortin Protein; Drug Synergism; Drug Therapy, Combination; Feeding Behavior; Fluoxetine; Hippocampus; Male; Neurogenesis; Rats; Thyroid Hormones; Triiodothyronine | 2010 |
Effect of triiodothyronine on 5-HT1A and 5-HT1B receptor expression in rat forebrain and on latency to feed in the novelty suppressed feeding test.
Topics: Analysis of Variance; Animals; Feeding Behavior; Fluoxetine; Male; Prosencephalon; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Triiodothyronine | 2010 |
Social stress-induced hypothyroidism is attenuated by antidepressant treatment in rats.
Topics: Adipose Tissue, Brown; Analysis of Variance; Animals; Antidepressive Agents; Body Weight; Corticosterone; Disease Models, Animal; Exploratory Behavior; Fluoxetine; Food Preferences; Hypothyroidism; Male; Organ Size; Radioimmunoassay; Rats; Rats, Wistar; Social Behavior; Stress, Psychological; Sucrose; Thyroxine; Time Factors; Triiodothyronine | 2012 |